http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0#Head
http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0#assertion
http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0#provenance
http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0#pubInfo
http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0#assertion
https://uts.nlm.nih.gov/uts/umls/concept/C0242792
http://wordnet-rdf.princeton.edu/lemma/compare
https://uts.nlm.nih.gov/uts/umls/concept/C0439044
http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0#provenance
http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0#assertion
http://www.w3.org/ns/prov#generatedAtTime
2021-12-16T19:33:47.684931
http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0#assertion
http://www.w3.org/ns/prov#wasGeneratedBy
S&T TWOC project version 2
http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0#version
http://www.w3.org/ns/prov#value
2
http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT
http://www.w3.org/2000/01/rdf-schema#label
with lenalidomide and dexamethasone alone ( Rd )
http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT-POSITION
http://www.w3.org/2000/01/rdf-schema#label
35
http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE
http://www.w3.org/2000/01/rdf-schema#label
compared
http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE-POSITION
http://www.w3.org/2000/01/rdf-schema#label
[221]
http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT
http://www.w3.org/2000/01/rdf-schema#label
lenalidomide and dexamethasone ( DRd ) significantly prolonged progression-free survival in transplant-ineligible patients with newly diagnosed multiple myeloma
http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT-POSITION
http://www.w3.org/2000/01/rdf-schema#label
62
http://www.w3.org/2000/01/rdf-schema#ABSTRACT-UID
http://twoc-nlp-database-server-1:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:6bnj8pcp&rows=50
6bnj8pcp
http://www.w3.org/2000/01/rdf-schema#SENTENCE
http://www.w3.org/2000/01/rdf-schema#label
PURPOSE The MAIA trial found that addition of daratumumab to lenalidomide and dexamethasone (DRd) significantly prolonged progression-free survival in transplant-ineligible patients with newly diagnosed multiple myeloma, compared with lenalidomide and dexamethasone alone (Rd).
http://www.w3.org/2000/01/rdf-schema#TRIPLE-UID
http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:6bnj8pcp-TRIPLE-ABSTRACT-5
6bnj8pcp-TRIPLE-ABSTRACT-5
https://uts.nlm.nih.gov/uts/umls/concept/C0242792
http://www.w3.org/2000/01/rdf-schema#label
progression-free survival
https://uts.nlm.nih.gov/uts/umls/concept/C0439044
http://www.w3.org/2000/01/rdf-schema#label
alone
http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0#pubInfo
http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0#assertion
http://www.w3.org/ns/prov#wasDerivedFrom
https://doi.org/10.1200/jco.20.01849
http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB
http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0#sig
http://purl.org/nanopub/x/hasSignature
Lb1K+ircLb75PUAzgiAxLkTCnqsuds7OlVNnX2L/WvaKNP3kzn3Wt0Z4c5lUgzS5DTcRsL0Vb9cvXPBJge05xs49UFJMB/jewD4Liau1HSWWxHmcB9y1D0aNiWO5V4axQZjMNELXMc1Geu53oAXsOxmJE2mEuG4N3MD/vPQT6V8=
http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0
http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0
http://www.w3.org/ns/prov#generatedAtTime
2021-12-16T19:33:47.684931
http://purl.org/np/RA97FzBE3mPt3mTQ4vMVRox4n9T8tEN_JE4JETupQUtm0
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-8954-0470